Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness.
暂无分享,去创建一个
H. D. de Koning | A. Zauber | M. van Ballegooijen | I. Lansdorp-Vogelaar | R. Meester | S. Saini | S. Vijan | F. van Hees
[1] M. Phipps,et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.
[2] Joshua T. Cohen,et al. Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold. , 2014, The New England journal of medicine.
[3] Ruth Etzioni,et al. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. , 2014, Annals of internal medicine.
[4] Judith R. Logan,et al. Colonoscopy utilization and outcomes 2000 to 2011. , 2014, Gastrointestinal endoscopy.
[5] J. Habbema,et al. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. , 2014, Annals of internal medicine.
[6] Stephanie E. Moser,et al. Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study , 2014, BMJ : British Medical Journal.
[7] Eric J Feuer,et al. Secular trends in colon and rectal cancer relative survival. , 2013, Journal of the National Cancer Institute.
[8] Zhuoqiao Wang,et al. Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening Strategies , 2013, Annals of Internal Medicine.
[9] J. Goodwin,et al. Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region. , 2013, JAMA internal medicine.
[10] Peter H. Schwartz,et al. Older adults and forgoing cancer screening: "I think it would be strange". , 2013, JAMA internal medicine.
[11] Douglas K Rex,et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. , 2012, Gastroenterology.
[12] L. Seeff,et al. Patterns of Colorectal Cancer Test Use, Including CT Colonography, in the 2010 National Health Interview Survey , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[13] P. Shekelle,et al. Screening for Colorectal Cancer: A Guidance Statement From the American College of Physicians , 2012, Annals of Internal Medicine.
[14] Ewout W Steyerberg,et al. How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? , 2011, Cancer.
[15] James S Goodwin,et al. Overuse of screening colonoscopy in the Medicare population. , 2011, Archives of internal medicine.
[16] Bruce Landon,et al. The incidence and cost of unexpected hospital use after scheduled outpatient endoscopy. , 2010, Archives of internal medicine.
[17] Cancer,et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.
[18] Charles J. Kahi,et al. Provider Recommendations for Colorectal Cancer Screening in Elderly Veterans , 2009, Journal of General Internal Medicine.
[19] Ann G Zauber,et al. Individualizing colonoscopy screening by sex and race. , 2009, Gastrointestinal endoscopy.
[20] D. Ransohoff,et al. Adverse Events After Outpatient Colonoscopy in the Medicare Population , 2009, Annals of Internal Medicine.
[21] J. Habbema,et al. A novel hypothesis on the sensitivity of the fecal occult blood test , 2009, Cancer.
[22] Sei J. Lee,et al. Impact of Age and Comorbidity on Colorectal Cancer Screening Among Older Veterans , 2009, Annals of Internal Medicine.
[23] Douglas K Rex,et al. American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2022 .
[24] M. Gail,et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Yikyung Park,et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Bernadette Mazurek Melnyk,et al. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.
[27] P. Maisonneuve,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.
[28] Angela Mariotto,et al. Cost of care for elderly cancer patients in the United States. , 2008, Journal of the National Cancer Institute.
[29] B. Levin,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.
[30] P. Bossuyt,et al. Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review , 2006, The American Journal of Gastroenterology.
[31] L. McMahon,et al. Univariate solutions in a multivariate world: can we afford to practice as in the "good old days"? , 2005, The American journal of managed care.
[32] A. Neugut,et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. , 2003, Journal of the National Cancer Institute.
[33] O. Kronborg,et al. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds , 2002, Gut.
[34] L. Walter,et al. Cancer screening in elderly patients: a framework for individualized decision making. , 2001, JAMA.
[35] R. Dittus,et al. Utility valuations for outcome states of colorectal cancer , 1999, American Journal of Gastroenterology.
[36] T. Church,et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.
[37] M. Weinstein,et al. Guidelines for Pharmacoeconomic Studies , 1997, PharmacoEconomics.
[38] P. J. Young,et al. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. , 1992, Gut.
[39] N. O. Jacobsen,et al. Polyps of the large intestine in Aarhus, Denmark. An autopsy study. , 1989, Scandinavian journal of gastroenterology.
[40] S. Moss,et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.
[41] J. Bombí,et al. Polyps of the colon in barcelona, Spain. An autopsy study , 1988, Cancer.
[42] Yrjö Collan,et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large‐bowel cancer , 1985, International journal of cancer.
[43] D W Day,et al. Polyps and cancer of the large bowel: a necropsy study in Liverpool. , 1982, Gut.
[44] M. Vatn,et al. The prevalence of polyps of the large intestine in Oslo: An autopsy study , 1982, Cancer.
[45] E. C. Hammond,et al. Adenomatous lesions of the large bowel: An autopsy survey , 1979, Cancer.
[46] T C ARMINSKI,et al. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations , 1964, Diseases of the colon and rectum.
[47] I CHAPMAN,et al. Adenomatous Polypi of Large Intestine: Incidence and Distribution , 1963, Annals of surgery.
[48] Lester J. Blatt,et al. Polyps of the colon and rectum , 1961 .
[49] A. Zauber,et al. The Appropriateness ofMore Intensive Colonoscopy Screening Than Recommended inMedicare Beneficiaries AModeling Study , 2014 .
[50] M. Johnston,et al. M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT , 2014 .
[51] Amy B. Knudsen,et al. Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer , 2007 .
[52] M C Weinstein,et al. Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. , 1997, PharmacoEconomics.